Balversa 4MG tabs
Ended Awarded
- Contract number
- 36C26024F0277
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,643
Award facts
- Contract value 100% obligated
- $17,642.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., has been awarded a $17,642.95 firm fixed price delivery order for BALVERSA 4MG tablets from the Department of Veterans Affairs Veterans Health Administration (VHA) under the company's Pharmaceuticals and Drugs (FSS-61-IB) multiple award schedule contract. The delivery order, which has no set-aside designation and expires March 31, 2024, will provide cancer treatment medications to the VHA's Veterans Integrated Service Network 20 facilities located in Carrollton, Texas. As the prime contractor, Janssen will deliver BALVERSA tablets and other specialty oncology drugs in support of healthcare services for veterans from its manufacturing facilities to VA medical centers and clinics across the country through July 2024.
Quick answers
Who was awarded contract 36C26024F0277?
36C26024F0277 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 8, 2024.
How much is contract 36C26024F0277 worth?
The government has obligated $17,643 on 36C26024F0277.
Is contract 36C26024F0277 an order under another contract?
Yes. 36C26024F0277 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0277 competed?
The extent of competition for 36C26024F0277 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award